Azenta, Inc. (AZTA)
34.09
-2.43
(-6.65%)
USD |
NASDAQ |
Oct 16, 16:00
34.11
+0.02
(+0.06%)
After-Hours: 20:00
Azenta SG&A Expense (TTM) : 257.38M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 257.38M |
| March 31, 2026 | 251.24M |
| December 31, 2025 | 254.94M |
| September 30, 2025 | 267.54M |
| June 30, 2025 | 277.85M |
| March 31, 2025 | 290.65M |
| December 31, 2024 | 297.37M |
| September 30, 2024 | 302.74M |
| June 30, 2024 | 305.65M |
| March 31, 2024 | 307.28M |
| December 31, 2023 | 302.31M |
| September 30, 2023 | 316.28M |
| June 30, 2023 | 306.06M |
| March 31, 2023 | 288.73M |
| December 31, 2022 | 283.90M |
| September 30, 2022 | 252.06M |
| June 30, 2022 | 267.81M |
| March 31, 2022 | 267.50M |
| December 31, 2021 | 260.88M |
| September 30, 2021 | 252.10M |
| June 30, 2021 | 220.82M |
| March 31, 2021 | 222.71M |
| December 31, 2020 | 220.62M |
| September 30, 2020 | 228.04M |
| June 30, 2020 | 232.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 225.20M |
| December 31, 2019 | 217.76M |
| September 30, 2019 | 211.96M |
| June 30, 2019 | 204.79M |
| March 31, 2019 | 194.34M |
| December 31, 2018 | 182.64M |
| September 30, 2018 | 167.02M |
| June 30, 2018 | 164.31M |
| March 31, 2018 | 162.18M |
| December 31, 2017 | 159.03M |
| September 30, 2017 | 153.06M |
| June 30, 2017 | 141.09M |
| March 31, 2017 | 132.93M |
| December 31, 2016 | 128.10M |
| September 30, 2016 | 130.26M |
| June 30, 2016 | 127.09M |
| March 31, 2016 | 123.06M |
| December 31, 2015 | 119.98M |
| September 30, 2015 | 115.27M |
| June 30, 2015 | 113.13M |
| March 31, 2015 | 115.35M |
| December 31, 2014 | 114.37M |
| September 30, 2014 | 111.73M |
| June 30, 2014 | 111.66M |
| March 31, 2014 | 104.22M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 1.844B |
| Bio-Rad Laboratories, Inc. | 852.20M |
| Bruker Corp. | 970.70M |
| Danaher Corp. | 7.949B |
| Harvard Bioscience, Inc. | 38.06M |